Corrigendum to definitive and sustained increase in prostate cancer metastases in the United States
Urol Oncol
.
2022 Jul;40(7):354.
doi: 10.1016/j.urolonc.2022.05.008.
Epub 2022 May 30.
Authors
Neal A Patel
1
,
Art Sedrakyan
2
,
Fernando Bianco
3
,
Ruth Etzioni
4
,
Michael A Gorin
5
,
Wei-Chun Hsu
2
,
Jialin Mao
2
,
Paul L Nguyen
6
,
Edward Schaeffer
7
,
Jonathan Shoag
1
,
Andrew Vickers
8
,
Jim C Hu
9
Affiliations
1
Department of Urology, Weill Cornell Medicine-New York Presbyterian Hospital, New York, NY.
2
Department of Healthcare Policy and Research, Weill Cornell Medicine, New York, NY.
3
Nova Southeastern University, Fort Lauderdale, FL.
4
Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA.
5
Department of Urology, Johns Hopkins University School of Medicine, Baltimore, MD.
6
Department of Radiation Oncology, Dana Farber Cancer Institute, Boston, MA.
7
Department of Urology, Feinberg School of Medicine, Northwestern University, Chicago, IL.
8
Department of Epidemiology, Memorial Sloan-Kettering Cancer Center, New York, NY.
9
Department of Urology, Weill Cornell Medicine-New York Presbyterian Hospital, New York, NY. Electronic address: jch9011@med.cornell.edu.
PMID:
35654645
DOI:
10.1016/j.urolonc.2022.05.008
No abstract available
Publication types
Published Erratum
Grants and funding
U01 CA253915/CA/NCI NIH HHS/United States
U01 FD006936/FD/FDA HHS/United States